Cell-free fetal nucleic acid testing: A review of the technology and its applications

Obstetrical and Gynecological Survey

Volumn 66, Issue 7, 2011, Pages 431-442

  Sayres, Lauren C ^a   Cho, Mildred K ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

ALLELE; ANEUPLOIDY; BLOOD GROUP TYPING; CELL FREE SYSTEM; CHROMOSOME; CHROMOSOME ABERRATION; DIAGNOSTIC TEST; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC SCREENING; GENOME; HUMAN; MASS SPECTROMETRY; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PREDICTION; PREGNANCY COMPLICATION; PRENATAL SCREENING; REVIEW; SEX DETERMINATION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VALIDITY;

BLOOD CHEMICAL ANALYSIS; CELL-FREE SYSTEM; DNA; FEMALE; FETAL DISEASES; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RNA; UNITED STATES;

EID: 80053295974     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31822dfbe2     Document Type: Review

References (144)

1. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet. 1969;1:1119-1122.
2. Simpson JL, Elias S. Isolating fetal cells in maternal circulation for prenatal diagnosis. Prenat Diagn. 1994;14:1229-1242.
3. Bianchi DW. Prenatal diagnosis by analysis of fetal cells in maternal blood. J Pediatr. 1995;127:847-856. (Pubitemid 26003275)
4. Steele CD, Wapner RJ, Smith JB, et al. Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clin Obstet Gynecol. 1996;39:801-813. (Pubitemid 26384622)
5. Bischoff FZ, Sinacori MK, Dang DD, et al. Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosis. Hum Reprod Update. 2002;8:493-500. (Pubitemid 35476796)
6. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485-487. (Pubitemid 27343304)
7. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn. 2007;27:415-418. (Pubitemid 47164339)
8. Sekizawa A, Yokokawa K, Sugito Y, et al. Evaluation of bidirectional transfer of plasma DNA through placenta. Hum Genet. 2003;113:307-310. (Pubitemid 37059112)
9. Wataganara T, Metzenbauer M, Peter I, et al. Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol. 2005;193:496-500. (Pubitemid 41159547)
10. Poon LL, Leung TN, Lau TK, et al. Presence of fetal RNA in maternal plasma. Clin Chem. 2000;46:1832-1834.
11. Birch L, English CA, O'Donoghue K, et al. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem. 2005;51:312-320. (Pubitemid 40175800)
12. Lo YM, Lau TK, Chan LY, et al. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem. 2000;46:1301-1309.
13. Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet. 1999;64:218-224. (Pubitemid 30428975)
14. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62:768-775. (Pubitemid 28194317)
15. Jorgez CJ, Simpson JL, Bischoff FZ. Recovery and amplification of placental RNA from dried maternal blood spots: utility for non-invasive prenatal diagnosis. Reprod Biomed Online. 2006;13:558-561. (Pubitemid 44548793)
16. Bischoff FZ, Dang DX, Marquez-Do D, et al. Detecting fetal DNA from dried maternal blood spots: another step towards broad scale non-invasive prenatal genetic screening and feasible testing. Reprod Biomed Online. 2003;6:349-351. (Pubitemid 36849783)
17. Poon LL, Leung TN, Lau TK, et al. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem. 2002;48:35-41. (Pubitemid 34038120)
18. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med. 2007;13:218-223.
19. Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91.
20. Fan H, Quake S. In principle method for noninvasive determination of the fetal genome. Nature Precedings. 2010. Available at: http://dx.doi.org/10.1038/ npre.2010.5373.1.
21. Nicolaides K, Brizot Mde L, Patel F, et al. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet. 1994;344:435-439. (Pubitemid 24248245)
22. Efrat Z, Perri T, Ramati E, et al. Fetal gender assignment by first-trimester ultrasound. Ultrasound Obstet Gynecol. 2006; 27:619-621. (Pubitemid 43967362)
23. ACOG Committee Opinion No. 360: Sex selection. Obstet Gynecol. 2007;109:475-478.
24. Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn. 2005;25:1111-1116. (Pubitemid 43016291)
25. Wald NJ, Morris JK. A new approach to antenatal screening for Fragile X syndrome. Prenat Diagn. 2003;23:345-351. (Pubitemid 36457273)
26. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med. 2005;7:584-587. (Pubitemid 41566485)
27. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med. 2002;346: 1502. (Pubitemid 34755726)
28. Santacroce R, Vecchione G, Tomaiyolo M, et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia. 2006;12: 417-422.
29. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133-4160.
30. Rijnders RJ, van der Schoot CE, Bossers B, et al. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol. 2001;98: 374-378.
31. Honda H, Miharu N, Ohashi Y, et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet. 2002; 110:75-79. (Pubitemid 36067421)
32. Costa JM, Benachi A, Gautier E, et al. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat Diagn. 2001;21:1070-1074. (Pubitemid 34056191)
33. Hromadnikova I, Houbova B, Hridelova D, et al. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat Diagn. 2003;23:235-238. (Pubitemid 36323685)
34. Sekizawa A, Kondo T, Iwasaki M, et al. Accuracy of fetal gender determination by analysis of DNA in maternal plasma. Clin Chem. 2001;47:1856-1858. (Pubitemid 32881203)
35. International Blood Group Reference Laboratory. Overview of IBCRL reference and diagnostic services. Available at: http://ibgrl.blood.co.uk/ ReferenceServices/RefServframes. htm. Accessed May 6, 2011.
36. Center for Medical Genetics. DNA fetal gender determination. Available at: http://www.geneticstesting.com/gendertest/gendertest.htm. Accessed May 6, 2011.
37. DNA Plus. Fetal cell/DNA prenatal gender test. 1996-2011. Available at: http://www.dnaplus.com/fetal-cell-prenatal-geder-test.htm. Accessed May 6, 2011.
38. Consumer Genetics. Early DNA gender predicting test: boy or girl? 2005-2011. Available at: http://www.tellmepinkorblue. com/Gender-Testing-Boy- Girl.php. Accessed May 6, 2011.
39. Prenatal Genetics Center. Prenatal gender testing on maternal blood: Y-chromosome detection. 2000-2010. Available at: http://www. prenatalgeneticscenter.com/gender-intro. asp. Accessed May 6, 2011.
40. Bianchi DW. At-home fetal DNA gender testing: caveat emptor. Obstet Gynecol. 2006;107:216-218.
41. Zand S. Parents sue over pregnancy test said to tell baby's sex. 2006. Available at: http://abcnews.go.com/Health/story?id-1668125&page-1.
42. Wright C. Cell-free fetal nucleic acids for noninvasive prenatal diagnosis: report of the UK expert working group. Cambridge, England: PHG Foundation; 2009.
43. Finning K, Martin P, Daniels G. The use of maternal plasma for prenatal RhD blood group genotyping. Methods Mol Biol. 2009;496:143-157.
44. Kolialexi A, Tounta G, Mavrou A. Noninvasive fetal RhD genotyping from maternal blood. Expert Rev Mol Diagn. 2010;10:285-296.
45. ACOG Practice Bulletin No. 75: management of alloimmunization. Obstet Gynecol. 2006;108:457-464.
46. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112:164-176.
47. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion. 2003;43:1661-1666. (Pubitemid 37518071)
48. Szczepura A, Bonsel G, Krauth C, et al. Fetal RHD typing: is fetal RHD typing in all RhD negative women cost effective? BMJ. 2008;336:906. (Pubitemid 351632011)
49. Ma K, Rodriguez MI, Cheng Y, et al. Should free fetal DNA testing replace antenatal anti-D administration for prevention of Rhesus alloimmunization? Am J Obstet Gynecol. 2011; 204(S1):A139.
50. Faas BH, Beuling EA, Christiaens GC, et al. Detection of fetal RHD-specific sequences in maternal plasma. Lancet. 1998; 352:1196. (Pubitemid 28458542)
51. Bischoff FZ, Nguyen DD, Marquez-Do D, et al. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig. 1999;6:64-69. (Pubitemid 29160198)
52. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol. 2006;195: 1163-1173. (Pubitemid 44415679)
53. Van der Schoot CE, Soussan AA, Koelewijn J, et al. Noninvasive antenatal RHD typing. Transfus Clin Biol. 2006;13: 53-57.
54. Lenetix Medical Screening Laboratory, Inc. RhD genotyping. 2003-2010. Available at: http://www.lenetix.com/html/rhd-sry-genotyping.html. Accessed May 6, 2011.
55. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ. 2008;336:816-818. (Pubitemid 351548224)
56. Ding C. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma. Methods Mol Biol. 2008;444: 253-267.
57. Li Y, Finning K, Daniels G, et al. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat Diagn. 2008;28:203-208. (Pubitemid 351427938)
58. Wright CF, Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update. 2009;15:139-151.
59. Sequenom, Inc. Sequenom announces launch of SensiGene fetal RHD genotyping test. 2010. Available at: http://phx. corporate-ir.net/phoenix.zhtml? c-84955&p-irol-newsArticle-pf&ID-1383114&highlight. Accessed May 6, 2011.
60. Hahn S, Zhong XY, Burk MR, et al. Multiplex and real-time quantitative PCR on fetal DNA in maternal plasma. A comparison with fetal cells isolated from maternal blood. Ann N Y Acad Sci. 2000;906:148-152. (Pubitemid 30255473)
61. Zhong XY, Holzgreve W, Hahn S. Risk free simultaneous prenatal identification of fetal Rhesus D status and sex by multiplex real-time PCR using cell free fetal DNA in maternal plasma. Swiss Med Wkly. 2001;131:70-74. (Pubitemid 32216319)
62. Finning K, Martin P, Summers J, et al. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion. 2007;47:2126-2133. (Pubitemid 47623982)
63. ACOG Committee Opinion No. 410: ethical issues in genetic testing. Obstet Gynecol. 2008;111:1495-1502.
64. Heckerling PS, Verp MS. A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing. Med Care. 1994;32:863-880.
65. Amicucci P, Gennarelli M, Novelli G, et al. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem. 2000;46:301-302. (Pubitemid 30104263)
66. Li Y, Holzgreve W, Page-Christiaens GC, et al. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn. 2004;24:896-898. (Pubitemid 39576805)
67. Fucharoen G, Tungwiwat W, Ratanasiri T, et al. Prenatal detection of fetal hemoglobin E gene from maternal plasma. Prenat Diagn. 2003;23:393-396. (Pubitemid 36596969)
68. Saito H, Sekizawa A, Morimoto T, et al. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet. 2000;356:1170.
69. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, et al. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn. 2003;23:232-234. (Pubitemid 36323684)
70. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, et al. Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR. Neurology. 2003;60: 1214-1215. (Pubitemid 36418797)
71. Bustamante-Aragones A, Trujillo-Tiebas MJ, Gallego-Merlo J, et al. Prenatal diagnosis of Huntington disease in maternal plasma: direct and indirect study. Eur J Neurol. 2008;15: 1338-1344.
72. Lazaros L, Hatzi E, Bouba I, et al. Non-invasive prenatal detection of paternal origin hb lepore in a male fetus at the 7th week of gestation. Fetal Diagn Ther. 2006;21:506-509. (Pubitemid 44804588)
73. Reed W, Kong DZ, Lee TH, et al. Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma. Bone Marrow Transplant. 2002;29:527-529. (Pubitemid 34428724)
74. Wagner J, Dzijan S, Marjanovic D, et al. Non-invasive prenatal paternity testing from maternal blood. Int J Legal Med. 2009;123:75-79.
75. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn. 2002;22:946-948. (Pubitemid 35176000)
76. Chiu RW, Lau TK, Cheung PT, et al. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem. 2002;48:778-780. (Pubitemid 34439114)
77. Nasis O, Thompson S, Hong T, et al. Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis. Clin Chem. 2004;50: 694-701. (Pubitemid 38429332)
78. Chiu RW, Lau TK, Leung TN, et al. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet. 2002;360:998-1000. (Pubitemid 35284114)
79. Lun FM, Tsui NB, Chan KC, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. P Natl Acad Sci USA. 2008;105:19920-19925.
80. Tsui NB, Kadir RA, Chan KC, et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood. 2011;117:3684-3691.
81. Ding C, Chiu RW, Lau TK, et al. MS analysis of singlenucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. P Natl Acad Sci USA. 2004;101:10762-10767. (Pubitemid 38955816)
82. Li Y, Di Naro E, Vitucci A, et al. Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDITOF mass spectrometry. Fetal Diagn Ther. 2009;25:246-249.
83. Li Y, Page-Christiaens GC, Gille JJ, et al. Non-invasive prenatal detection of achondroplasia in size-fractionated cellfree DNA by MALDI-TOF MS assay. Prenat Diagn. 2007;27: 11-17. (Pubitemid 46144334)
84. Li Y, Zimmermann B, Rusterholz C, et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem. 2004;50:1002-1011. (Pubitemid 38725787)
85. Li Y, Di Naro E, Vitucci A, et al. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA. 2005;293:843-849. (Pubitemid 40250368)
86. Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem. 2004; 50:88-92. (Pubitemid 38125703)
87. Jorgez CJ, Bischoff FZ. Improving enrichment of circulating fetal DNA for genetic testing: size fractionation followed by whole gene amplification. Fetal Diagn Ther. 2009;25:314-319.
88. Hahn T, Drese KS, O'Sullivan CK. Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation. Clin Chem. 2009;55:2144-2152.
89. Galbiati S, Restagno G, Foglieni B, et al. Different approaches for noninvasive prenatal diagnosis of genetic diseases based on PNA-mediated enriched PCR. Ann N Y Acad Sci. 2006;1075:137-143. (Pubitemid 44532776)
90. Hassold T, Abruzzo M, Adkins K, et al. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen. 1996; 28:167-175. (Pubitemid 26380273)
91. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353:2001-2011. (Pubitemid 41609093)
92. Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG. 2003; 110:281-286. (Pubitemid 36298912)
93. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110: 1459-1467.
94. Odibo AO, Stamilio DM, Nelson DB, et al. A costeffectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol. 2005;106:562-568. (Pubitemid 41208790)
95. Hahn S, Jackson LG, Kolla V, et al. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn. 2009;9: 613-621.
96. Wright C, Quake SR, Bianchi D, et al. Community corner: opening the Pandora's box of prenatal genetic testing. Nat Med. 2011;17:250-251.
97. Chim SS, Tong YK, Chiu RW, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. P Natl Acad Sci USA. 2005;102:14753-14758. (Pubitemid 41457128)
98. Tong YK, Ding C, Chiu RW, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem. 2006;52:2194-2202. (Pubitemid 44924992)
99. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem. 2006;52:2211-2218. (Pubitemid 44924994)
100. Old RW, Crea F, Puszyk W, et al. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome. Reprod Biomed Online. 2007;15:227-235. (Pubitemid 47263333)
101. Nygren AO, Dean J, Jensen TJ, et al. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin Chem. 2010;56:1627-1635.
102. Oudejans CB, Go AT, Visser A, et al. Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. Clin Chem. 2003;49:1445-1449. (Pubitemid 37011731)
103. Deng YH, Yin AH, He Q, et al. Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification. Clin Chem Lab Med. 2011;49:641-646.
104. Tsui NB, Chim SS, Chiu RW, et al. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet. 2004;41:461-467. (Pubitemid 38788044)
105. Zimmermann B, Holzgreve W, Wenzel F, et al. Novel realtime quantitative PCR test for trisomy 21. Clin Chem. 2002; 48:362-363. (Pubitemid 34107277)
106. Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. P Natl Acad Sci USA. 2007;104:13116-13121. (Pubitemid 351737602)
107. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem. 2007;79:7576-7579. (Pubitemid 47606128)
108. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. P Natl Acad Sci USA. 2008;105:20458-20463.
109. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. P Natl Acad Sci USA. 2008;105:16266-16271.
110. Liao GJ, Lun FM, Zheng YW, et al. Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem. 2011;57:92-101.
111. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One. 2010;5:e10439.
112. Lun FM, Jin YY, Sun H, et al. Noninvasive prenatal diagnosis of a case of Down syndrome due to Robertsonian translocation by massively parallel sequencing of maternal plasma DNA. Clin Chem. 2011;57.
113. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342: c7401.
114. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detec-tion of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:e201-e211.
115. Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem. 2011;57.
116. Ghanta S, Mitchell ME, Ames M, et al. Non-invasive prenatal detection of trisomy 21 using tandem single nucleotide polymorphisms. PLoS One. 2010;5:e13184.
117. Norbury G, Norbury CJ. Non-invasive prenatal diagnosis of single gene disorders: how close are we? Seminin Fetal Neonatal Med. 2008;13:76-83.
118. Sekizawa A, Farina A, Sugito Y, et al. Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin Chem. 2004;50:221-224. (Pubitemid 38125727)
119. Lo YM, Leung TN, Tein MS, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184-188. (Pubitemid 29079115)
120. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy. 2002;21: 77-83. (Pubitemid 34437747)
121. Farina A, Sekizawa A, Sugito Y, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn. 2004;24:83-86. (Pubitemid 38294411)
122. Sekizawa A, Jimbo M, Saito H, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem. 2002;48:353-354. (Pubitemid 34107273)
123. Sekizawa A, Sugito Y, Iwasaki M, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem. 2001;47:2164-2165. (Pubitemid 33108887)
124. Leung TN, Zhang J, Lau TK, et al. Maternal plasma fetal DNA as a marker for preterm labour. Lancet. 1998;352:1904-1905. (Pubitemid 28561255)
125. Zhong XY, Laivuori H, Livingston JC, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184:414-419. (Pubitemid 32206993)
126. Sekizawa A, Jimbo M, Saito H, et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol. 2003;188:480-484. (Pubitemid 36249989)
127. Maron JL, Johnson KL, Slonim D, et al. Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest. 2007;117:3007-3019. (Pubitemid 47529630)
128. Purwosunu Y, Sekizawa A, Farina A, et al. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn. 2007;27:772-777. (Pubitemid 47242409)
129. Farina A, Sekizawa A, Purwosunu Y, et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn. 2006;26:1115-1120. (Pubitemid 44935273)
130. Ng EK, Leung TN, Tsui NB, et al. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem. 2003; 49:727-731. (Pubitemid 36513250)
131. Annas GJ. Ethical aspects of non-invasive prenatal diagnosis: medical, market, or regulatory model? Early Hum Dev. 1996;47:S5-S11. (Pubitemid 27050926)
132. Benn PA, Chapman AR. Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA. 2009;301:2154-2156.
133. Benn PA, Chapman AR. Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol. 2010;22:128-134.
134. Deans Z, Newson AJ. Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Anal. 2010;19:122-132.
135. Greely HT, King JS. The coming revolution in prenatal genetic testing. Prof Ethics Rep. 2010;23:1-3.
136. Hall A, Bostanci A, John S. Cell-free fetal nucleic acids for noninvasive prenatal diagnosis: report of the UK expert working group. Cambridge, England: PHG Foundation; 2009. Appendix III, Ethical, legal, and social issues arising from cell-free fetal DNA technologies.
137. Hall A, Bostanci A, Wright CF. Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics. 2010;13:246-255.
138. Kent A. Non-invasive prenatal diagnosis: public and patient perceptions. Semin Fetal Neonatal Med. 2008;13:109-112. (Pubitemid 351227395)
139. Newson AJ. Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med. 2008;13:103-108.
140. Ravitsky V. Non-invasive prenatal diagnosis: an ethical imperative. Nat Rev Genet. 2009;10:733; author reply 733.
141. Schmitz D, Henn W, Netzer C. Commentary: no risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing. BMJ. 2009;339:b2690.
142. Schmitz D, Netzer C, Henn W. An offer you can't refuse? Ethical implications of non-invasive prenatal diagnosis. Nat Rev Genet. 2009;10:515.
143. Smith RP, Lombaard H, Soothill PW. The obstetrician's view: ethical and societal implications of non-invasive prenatal diagnosis. Prenat Diagn. 2006;26:631-634. (Pubitemid 44146778)
144. Wright CF, Chitty LS. Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing. BMJ. 2009;339:b2451.